Showing results (1-10 of 128) with videos related to
Sort By:
Pageof 13
Journal of Preventive Medicine and Hygiene|January 6, 2025
Change management for services redesign in healthcare: a conceptual frameworkSofia Silvola, Umberto Restelli, Davide Croce, et al.Clinicoeconomics and Outcomes Research : CEOR|May 23, 2023
Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature ReviewSofia Silvola, Umberto Restelli, Marzia Bonfanti, et al.Journal of Health Care Finance|February 15, 2012
Introduction of concept of cost centre management in a public hospital in South AfricaDebashis Basu, Davide Croce, Emanuele Porazzi, et al.Jac-Antimicrobial Resistance|April 24, 2023
Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitalsFrancesca Bai, Maria Mazzitelli, Sofia Silvola, et al.Journal of Preventive Medicine and Hygiene|August 15, 2022
Analysis of the correlation between mortality in nursing homes and among elderly population in Italy during the first phase of COVID-19 pandemicAntonio Sebastiano, Umberto Restelli, Sofia Silvola, et al.Clinicoeconomics and Outcomes Research : CEOR|August 20, 2016
Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectivesDavide Croce, Marzia Bonfanti, Umberto RestelliClinical Drug Investigation|July 11, 2020
Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XRUmberto Restelli, Manuel García-Goñi, Michal Lew-Starowicz, et al.BMC Infectious Diseases|August 12, 2015
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)Umberto Restelli, Francesca Scolari, Paolo Bonfanti, et al.Infection and Drug Resistance|June 14, 2019
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in ItalyUmberto Restelli, Davide Croce, Valeria Pacelli, et al.Clinicoeconomics and Outcomes Research : CEOR|March 11, 2017
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trialUmberto Restelli, Massimiliano Fabbiani, Simona Di Giambenedetto, et al.Pageof 13